pomalidomide

Italy

Drugs containing this active substance

  • IMNOVID

    Imnovid is used for the treatment of adults with multiple myeloma, a type of cancer that affects plasma cells (a type of white blood cell) in the bone marrow.

    Form: capsules, hard gelatin

    Active substance Dosage
    pomalidomide -

    ATC: L04AX06

    Manufacturer: BRISTOL-MYERS SQUIBB PHARMA EEIG

  • It is used for the treatment of adults with multiple myeloma, a type of cancer that affects plasma cells (a type of white blood cell) in the bone marrow. It may be taken together with bortezomib and dexamethasone, or only with dexamethasone, depending on the specific case.

    Form: capsules, hard gelatin

    Active substance Dosage
    pomalidomide -

    ATC: L04AX06

    Manufacturer: Abdi Farma GmbH

  • It is used for the treatment of adults with multiple myeloma, a type of cancer that affects plasma cells (a type of white blood cell). It may be used in combination with other medicines such as bortezomib and dexamethasone, or alone with dexamethasone, depending on the patient's clinical situation.

    Form: capsules, hard gelatin

    Active substance Dosage
    pomalidomide -

    ATC: L04AX06

    Manufacturer: ACCORD HEALTHCARE, S.L.U.

  • It is used for the treatment of adults with multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. It may be taken together with bortezomib and dexamethasone, or only with dexamethasone, depending on the specific case.

    Form: capsules, hard gelatin

    Active substance Dosage
    pomalidomide -

    ATC: L04AX06

    Manufacturer: Eugia Pharma (Malta) Limited

  • It is used for the treatment of adults with multiple myeloma, a type of cancer that affects plasma cells (a type of white blood cell) in the bone marrow.

    Form: capsules, hard gelatin

    Active substance Dosage
    pomalidomide -

    ATC: L04AX06

    Manufacturer: EG S.P.A.

  • It is used for the treatment of adults with multiple myeloma, a type of cancer that affects plasma cells (a type of white blood cell) in the bone marrow.

    Form: capsules, hard gelatin

    Active substance Dosage
    pomalidomide -

    ATC: L04AX06

    Manufacturer: EVER PHARMA ITALIA S.R.L.

  • It is used for the treatment of adults with multiple myeloma, a type of cancer that affects plasma cells (a type of white blood cell) in the bone marrow.

    Form: capsules, hard gelatin

    Active substance Dosage
    pomalidomide -

    ATC: L04AX06

    Manufacturer: G.L. PHARMA GMBH

  • It is used in the treatment of adults with multiple myeloma, a type of cancer that affects plasma cells (a type of white blood cell) in the bone marrow.

    Form: capsules, hard gelatin

    Active substance Dosage
    pomalidomide -

    ATC: L04AX06

    Manufacturer: GLENMARK PHARMACEUTICALS S.R.O.

  • It is used for the treatment of adults with multiple myeloma, a type of cancer that affects plasma cells (a type of white blood cell) in the bone marrow.

    Form: capsules, hard gelatin

    Active substance Dosage
    pomalidomide -

    ATC: L04AX06

    Manufacturer: AS GRINDEKS

  • It is used for the treatment of adults with multiple myeloma, a type of cancer that affects plasma cells (white blood cells) in the bone marrow. It may be taken together with bortezomib and dexamethasone, or only with dexamethasone, depending on the specific case.

    Form: capsules, hard gelatin

    Active substance Dosage
    pomalidomide -

    ATC: L04AX06

    Manufacturer: KRKA D.D. NOVO MESTO

  • It is used for the treatment of adults with multiple myeloma, a type of cancer that affects plasma cells (a type of white blood cell) in the bone marrow. It may be taken together with bortezomib and dexamethasone, or only with dexamethasone, depending on the patient's clinical situation.

    Form: capsules, hard gelatin

    Active substance Dosage
    pomalidomide -

    ATC: L04AX06

    Manufacturer: LABORATORIO REIG JOFRE, S.A.

  • It is used for the treatment of adults with multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. It may be taken together with bortezomib and dexamethasone, or only with dexamethasone, depending on the specific case.

    Form: capsules, hard gelatin

    Active substance Dosage
    pomalidomide -

    ATC: L04AX06

    Manufacturer: SANDOZ S.P.A.

  • It is used in the treatment of adults with multiple myeloma, a type of cancer that affects plasma cells (a type of white blood cell) and can cause damage to the bones and kidneys.

    Form: capsules, hard gelatin

    Active substance Dosage
    pomalidomide -

    ATC: L04AX06

    Manufacturer: TEVA GMBH

  • It is used in the treatment of adults suffering from a type of cancer called multiple myeloma. It may be taken together with bortezomib and dexamethasone, or together with dexamethasone alone, depending on the specific case.

    Form: capsules, hard gelatin

    Active substance Dosage
    pomalidomide -

    ATC: L04AX06

    Manufacturer: VIATRIS LIMITED

  • It is used for the treatment of adults with multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. It may be taken together with bortezomib and dexamethasone, or only with dexamethasone, depending on the specific case.

    Form: capsules, hard gelatin

    Active substance Dosage
    pomalidomide -

    ATC: L04AX06

    Manufacturer: ZENTIVA K.S.